Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Izzi-Engbeaya C"'
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide, affecting up to 30% of adults. Progression to non-alcoholic steatohepatitis (NASH) is a key risk factor for cirrhosis, hepatocellular carcinoma and cardiovascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::6c93809fad3610bf93d6136f14ee63a2
http://hdl.handle.net/10044/1/105204
http://hdl.handle.net/10044/1/105204
Autor:
Adams, S, Voliotis, M, Phylactou, M, Izzi-Engbeaya, C, Mills, E, Thurston, L, Hanassab, S, Tsaneva-Atanasova, K, Heinis, T, Comninos, A, Abbara, A, Dhillo, W
Publikováno v:
Society for Endocrinology BES 2022
Objective Using a systematic review and meta-analysis, we aimed to estimate the mean effect of acute glucagon administration on components of energy balance and glucose homeostasis in adults without diabetes. Methods CENTRAL, CINAHL, Embase, MEDLINE,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::158dc0b74cc7c4c241cdad02bfe91173
http://hdl.handle.net/10044/1/99623
http://hdl.handle.net/10044/1/99623
Autor:
Johnson, H, Piggin, M, Abbara, A, Izzi-Engbeaya, C, Scholtz, S, Webber, L, Jayasena, C, Tan, T
Summary report on the views of members of the public on the proposed research on weight and fertility by the Metabolic Medicine and Endocrinology Theme of the Imperial Biomedical Research Centre.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aec95e93b77e40b3e731b5c23798056
http://hdl.handle.net/10044/1/94141
http://hdl.handle.net/10044/1/94141
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Izzi-Engbeaya, C, Comninos, AN, Clarke, SA, Jomard, A, Yang, L, Jones, S, Abbara, A, Narayanaswamy, S, Eng, PC, Papadopoulou, D, Prague, JK, Bech, P, Godsland, IF, Bassett, P, Sands, C, Camuzeaux, S, Gomez-Romero, M, Pearce, JTM, Lewis, MR, Holmes, E, Nicholson, JK, Tan, T, Ratnasabapathy, R, Hu, M, Carrat, G, Piemonti, L, Bugliani, M, Marchetti, P, Johnson, PR, Hughes, SJ, Shapiro, AM, Rutter, GA, Dhillo, WS
Publikováno v:
Diabetes, Obesity & Metabolism
Aims To investigate the effect of kisspeptin on glucose‐stimulated insulin secretion and appetite in humans. Materials and methods In 15 healthy men (age: 25.2 ± 1.1 years; BMI: 22.3 ± 0.5 kg m−2), we compared the effects of 1 nmol kg−1 h−1
Autor:
Abbara, A, Narayanaswamy, S, Izzi-Engbeaya, C, Comninos, A, Clarke, S, Malik, Z, Papadopoulou, D, Coblentz, A, Sarang, Z, Bassett, P, Jayasena, C, Dhillo, W
Background: Male testosterone levels decline by 1% per year from the age of 40yrs. Whilst a primary testicular deficit occurs, hypothalamic or pituitary dysregulation may also coexist. This study aimed to compare the hypothalamic response to kisspept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::fe1d6fa5230144433557d882735e1138
http://hdl.handle.net/10044/1/58408
http://hdl.handle.net/10044/1/58408
Autor:
Abbara, A, Clarke, S, Islam, R, Prague, J, Comninos, A, Narayanaswamy, S, Papadopoulou, D, Roberts, R, Izzi-Engbeaya, C, Ratnasabapathy, R, Nesbitt, A, Vimalesvaran, S, Salim, R, Lavery, S, Bloom, S, Huson, L, Trew, G, Dhillo, W
STUDY QUESTION Can increasing the duration of LH-exposure with a second dose of kisspeptin-54 improve oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS)? SUMMARY ANSWER A second dose of kisspeptin-54 at 10 h following
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::0f6dc70b6d209f775fa085795e1cbffd
http://hdl.handle.net/10044/1/71154
http://hdl.handle.net/10044/1/71154
Autor:
Abbara, A, Clarke, SA, Islam, R, Prague, JK, Comninos, AN, Narayanaswamy, S, Papadopoulou, D, Roberts, R, Izzi-Engbeaya, C, Ratnasabapathy, R, Nesbitt, A, Vimalesvaran, S, Salim, R, Lavery, S, Bloom, S, Huson, L, Trew, G, Dhillo, WS
STUDY QUESTION Can increasing the duration of LH-exposure with a second dose of kisspeptin-54 improve oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS)? SUMMARY ANSWER A second dose of kisspeptin-54 at 10 h following
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::9658a2d16c822b6fc51f94b45d41c1eb
http://hdl.handle.net/10044/1/50144
http://hdl.handle.net/10044/1/50144